{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:42:02Z","timestamp":1778042522548,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671594"],"award-info":[{"award-number":["81671594"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571591"],"award-info":[{"award-number":["81571591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.intimp.2018.01.046","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T08:31:32Z","timestamp":1517646692000},"page":"285-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis"],"prefix":"10.1016","volume":"56","author":[{"given":"Zaixing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhencheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanwan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renqian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.01.046_bb0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2018.01.046_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature","volume":"56","author":"de Liso","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10003","key":"10.1016\/j.intimp.2018.01.046_bb0015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2018.01.046_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-009-0164-5","article-title":"Primary biliary cirrhosis","volume":"31","author":"Hohenester","year":"2009","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.intimp.2018.01.046_bb0025","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"44","key":"10.1016\/j.intimp.2018.01.046_bb0030","doi-asserted-by":"crossref","first-page":"e1888","DOI":"10.1097\/MD.0000000000001888","article-title":"The distribution and the fibrotic role of elevated inflammatory Th17 cells in patients with primary biliary cirrhosis","volume":"94","author":"Shi","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2018.01.046_bb0035","doi-asserted-by":"crossref","first-page":"436450","DOI":"10.1155\/2015\/436450","article-title":"Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases","volume":"2015","author":"Zhang","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.intimp.2018.01.046_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","article-title":"Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis","volume":"157","author":"Harada","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2018.01.046_bb0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/1744666X.2016.1147956","article-title":"Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis","volume":"12","author":"Choi","year":"2016","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.01.046_bb0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.22102","article-title":"Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells","volume":"47","author":"Shimoda","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2018.01.046_bb0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.gene.2006.02.001","article-title":"Identification and expression of novel isoforms of human stromal cell-derived factor 1","volume":"374","author":"Yu","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2018.01.046_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2016.06.006","article-title":"CXCR4 signaling in health and disease","volume":"177","author":"Pozzobon","year":"2016","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.intimp.2018.01.046_bb0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.LAB.0000067498.89585.06","article-title":"Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases","volume":"83","author":"Terada","year":"2003","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.intimp.2018.01.046_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2018.01.046_bb0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.intimp.2018.01.046_bb0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.intimp.2018.01.046_bb0085","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc. R. Soc. Med."},{"issue":"5","key":"10.1016\/j.intimp.2018.01.046_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.arcmed.2010.07.001","article-title":"Assessment of CXCL12 (SDF-1\u03b1) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in southeastern Iran","volume":"41","author":"Hassanshahi","year":"2010","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.intimp.2018.01.046_bb0095","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/eji.200324441","article-title":"Involvement of the CXCL12\/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus","volume":"34","author":"Wald","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.01.046_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2018.01.046_bb0105","doi-asserted-by":"crossref","first-page":"G203","DOI":"10.1152\/ajpgi.00193.2016","article-title":"Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases","volume":"311","author":"Liepelt","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918300468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918300468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:09:23Z","timestamp":1761584963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918300468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":21,"alternative-id":["S1567576918300468"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.01.046","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}